Jana Tomisch

3PUBLICATIONS
9CO-AUTHORS
Molecular targetsSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Dec 03, 2025
A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells.

Jana Tomisch, Jonas Gräber, Olga N Makshakova

|Jul 29, 2023
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells.

Jana Tomisch, Vincent Busse, Francesca Rosato

|Dec 09, 2022
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.

Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch

Pageof 1

Frequent Collaborators

3 joint publications

Winfried Römer

2 joint publications

Francesca Rosato

2 joint publications

Olga N Makshakova

2 joint publications

Anne Imberty

1 joint publications

Rajeev Pasupuleti

1 joint publications

Ana Valeria Meléndez

1 joint publications

Dajana Kolanovic

1 joint publications

Birgit Wiltschi

1 joint publications

Annabelle Varrot

Frequent Collaborators

3 joint publications

Winfried Römer

2 joint publications

Francesca Rosato

2 joint publications

Olga N Makshakova

2 joint publications

Anne Imberty

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.4K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.7K
See more related videos

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.4K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.7K
See more related videos